At LewRockwell.com, Brian Shilhavy explains that the CDC’s quiet announcement that it will no longer use the Real-Time RT PCR Diagnostic Panel (aka) the PCR test, for COVID-19. He writes:
The CDC quietly announced last week that it was withdrawing its request to the FDA for Emergency Use Authorization (EUA) of the 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2.
Most of the public is probably unaware that similar to the current COVID-19 injections that are not yet approved by the FDA, but only given Emergency Use Authorization, so too the hundreds of diagnostic tests that supposedly detect COVID-19 are also NOT approved by the FDA, but only authorized via an EUA.
What is the reason the CDC is withdrawing its EUA request for the Real-Time RT-PCR Diagnostic Panel?
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test.
CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. (Source.).
The ending of the EUA for the Real-Time RT-PCR Diagnostic Panel will not happen until the end of the year, December 31, 2021, and the CDC recommends that laboratories start transitioning to other types of COVID-19 diagnostic tests that have been given an EUA by the FDA here.
At the time of publication of this article, the FDA has issued 251 EUAs for COVID-19 diagnostic tests since April 1, 2020. The vast majority of them are for the RT-PCR tests, including about 20 that were just issued EUAs since the beginning of this month, July, 2021.
The cash cow for these tests and the hundreds of companies that got rich selling them will now have to move on to the next phase to be able to cash in.
Read more here.
If you’re willing to fight for Main Street America, click here to sign up for my free weekly email.